Vicent Llorca-Bofí, Santiago Madero, Silvia Amoretti, Manuel J Cuesta, Carmen Moreno, Ana González-Pinto, Dani Bergé, Roberto Rodriguez-Jimenez, Alexandra Roldán, María Ángeles García-León, Angela Ibáñez, Judith Usall, Fernando Contreras, Gisela Mezquida, Clemente García-Rizo, Esther Berrocoso, Miquel Bernardo, Miquel Bioque
BACKGROUND: The clinical course following a first episode of schizophrenia (FES) is often characterized by recurrent relapses, resulting in unfavorable clinical and functional outcomes. Inflammatory dysregulation has been implicated in relapse risk; however, the predictive value of inflammatory blood cells in clinically remitted patients after a FES has not been previously explored. METHODS: In this study, we closely monitored 111 patients in remission after a FES until relapse or a three-year follow-up endpoint...
March 20, 2024: Schizophrenia Research